Ligand Pharma (LGND) Enters Captisol Licensing Agreement with Vireo Health
Tweet Send to a Friend
Ligand Pharma (NASDAQ: LGND) disclosed the following on Wednesday:On November 19, 2015, Ligand Pharmaceuticals Incorporated (“Ligand”) entered into a License ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
